BBOTVSNUS• 3 Months (Normalized)
BBOT vs NUS (BridgeBio Oncology Therapeutics Inc. vs Nu Skin Enterprises Inc.)
Showing Closing Date Range from Jul 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.5
-61.5%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
NUS Performance $4.74
-7.6%
Nu Skin Enterprises Inc.
Normalized Baseline0.00%
Alpha Spread Margin NUS LEADS
-53.9 pts
NUS outperforming by 53.90 percentage points
BBOTNUS
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT NUS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BBOT Price | BBOT Gain (%) | NUS Price | NUS Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.50 | -61.50% | $4.74 | -7.60% | -53.90% |
| Oct 05, 2026 | $3.60 | -60.40% | $4.63 | -9.75% | -50.65% |
| Oct 02, 2026 | $3.89 | -57.21% | $4.61 | -10.14% | -47.07% |
| Sep 30, 2026 | $4.10 | -54.90% | $- | - | |
| Sep 29, 2026 | $3.92 | -56.88% | $- | - | |
| Sep 28, 2026 | $3.81 | -58.09% | $- | - | |
| Sep 25, 2026 | $3.95 | -56.55% | $- | - | |
| Sep 24, 2026 | $3.99 | -56.11% | $4.62 | -9.94% | -46.17% |
| Sep 23, 2026 | $4.16 | -54.24% | $4.61 | -10.14% | -44.10% |
| Sep 22, 2026 | $4.66 | -48.73% | $- | - | |
| Sep 21, 2026 | $4.66 | -48.73% | $4.68 | -8.77% | -39.96% |
| Sep 18, 2026 | $4.77 | -47.52% | $4.58 | -10.72% | -36.80% |
| Sep 17, 2026 | $4.89 | -46.20% | $4.60 | -10.33% | -35.87% |
| Sep 16, 2026 | $4.76 | -47.63% | $4.58 | -10.72% | -36.91% |
| Sep 15, 2026 | $4.88 | -46.31% | $4.74 | -7.60% | -38.71% |
Page 1 of 5